| ST002319 Mass spectroscopy‑based proteomics and metabolomics analysis of triple‑positive breast cancer cells treated with tamoxifen and trastuzumab | ||||
| Limit by pathway class: | ||||
| ST002319 Mass spectroscopy‑based proteomics and metabolomics analysis of triple‑positive breast cancer cells treated with tamoxifen and trastuzumab | ||||
| Limit by pathway class: | ||||
|